AG3340 selective inhibitor of matrix metalloproteases involved in metastasis: Phase I testing

Agouron Pharmaceuticals Inc. (AGPH), La Jolla, Calif. Product: AG3340 selective inhibitor of matrix metalloproteases involved in metastasis Indication: Cancer Status: AGPH and partner Hoffmann-La Ro...